Fourth edition of the Sanofi iAwards Europe program - Call for Pre-Proposals 2021

Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care.

The Sanofi Innovation Awards (iAwards) program was created in the US, and was launched in 2018 in Europe.

Sanofi’s main objective in creating the iAwards program is to convert successful and promising iAwards projects to sponsored research programs and subsequently create in-licensing and start-up opportunities with the potential to continuously enrich Sanofi’s early stage portfolio. The funding level and duration for iAwards which are chosen for conversion into sponsored research projects will be based on the project needs.

In November 2017, Sanofi launched the iAwards program in Europe and a total of 48 projects were selected in 2018, 2019. On this occasion, several Institut Pasteur scientists were rewarded :

Lire le BIP du 14 juin 2019

Lire le BIP du 12 juin 2020

Following the great success of the first three calls for projects, Sanofi is delighted to launch the fourth edition of the Sanofi iAwards Europe program.

This year the therapeutic areas of interest are:
•    Molecular Oncology
•    Immunology & Inflammation
•    Immuno-oncology
•    Genomic Medicine
•    Neurological Disorders
•    Rare Diseases
•    Vaccines

All pre-proposals must be submitted by the partner to Sanofi by May 23rd, 2021 at the latest.

Should you have any further questions, please feel free to contact: sanofiiawards@pasteur.fr.

 

Read the call for preproposal

Download pre-proposal template